NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the Canaccord Genuity 44th Annual Growth Conference on Tuesday, […]
Category Archives: Pr Newswire
Pr Newswire
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
08
Aug
Aug
Over 122,000 prescriptions for VOQUEZNA® products written by healthcare providers, launch to date, a 184% increase since last quarterly report Net revenues of $7.3 million reported for the second quarter 2024 compared to $1.9 million in the first quarter 2024, greater than a 280% increase VOQUEZNA (vonoprazan) tablets 10mg now FDA-approved and available to treat […]
Pr Newswire
Evaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in September
08
Aug
Aug
COPENHAGEN, Denmark, Aug. 08, 2024 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, is proud to announce the presentation of one-year clinical efficacy Phase 2 data for its lead compound EVX-01 at the European Society for Medical Oncology (ESMO) Congress 2024, taking place in […]
08
Aug
Aug
FARMINGTON HILLS, Mich., Aug. 08, 2024 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of patients with retinal and refractive eye disorders, today announced that George Magrath, M.D., M.B.A., M.S., Chief Executive Officer, will present at the Canaccord Genuity 44th […]
08
Aug
Aug
SAN DIEGO, Aug. 08, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that Dr. Nathan Mata, Chief Scientific Officer of Belite Bio, will present a corporate update at the H.C. Wainwright […]
LOS ANGELES, Aug. 8, 2024 /PRNewswire/ — Global Bridge Associates (GBA), a leading study abroad and homestay organization, is excited to announce significant business growth and the launch of its newly redesigned website. This expansion reflects GBA’s commitment to enhancing international education experiences and providing exceptional, personalized support to exchange students and host families worldwide. […]
PARIS, Aug. 8, 2024 /PRNewswire/ — Hou Zhihui, representing the Chinese national team and the Hunan Zoomlion Weightlifting Team, achieved a stunning victory in the women’s 49kg weightlifting category at the Paris Olympics. Despite trailing in the snatch and facing a win-or-bust moment in her final clean and jerk attempt, Hou made an incredible comeback […]
SINGAPORE, Aug. 8, 2024 /PRNewswire/ — Trinasolar, a global leader in smart PV and energy storage solutions has entered into a research collaboration with the Agency for Science, Technology and Research (A*STAR) Singapore’s lead public sector R&D agency. This collaboration aims to advance the optimization and upgrading of industrial battery manufacturing technologies, contributing to the green and […]
Exicom to acquire business and assets of Tritium, a distinguished global leader in DC Fast Chargers, headquartered in Australia Acquisition seen as an ideal anchor towards building a global EV charger business with Tritium’s presence in 47 countries Exicom will have access to Tritium’s cutting-edge manufacturing facility in Tennessee, USA, as well as a world-class […]
SHANGHAI, Aug. 8, 2024 /PRNewswire/ — ZKH Group Limited (“ZKH” or the “Company”) (NYSE: ZKH), a leading maintenance, repair and operations (“MRO”) procurement service platform in China, today announced that it will release its unaudited financial results for the second quarter of 2024, on Thursday, August 22, 2024, before the open of the U.S. markets. […]